Emerald Mutual Fund Advisers Trust Has $14 25 Million Position in Insmed Incorporated (NASDAQ:INSM) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Investment analysts at Guggenheim assumed coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a report released on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $50.00 price target on the biopharmaceutical company’s stock. Guggenheim’s target price would indicate a potential upside of 145.10% from the stock’s current price. Separately, […]
EFG Asset Management North America Corp Reduces Position in Insmed Incorporated (NASDAQ:INSM) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Insmed Incorporated (NASDAQ:INSM) Given Consensus Recommendation of Buy by Brokerages kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Insmed Incorporated (NASDAQ:INSM – Free Report) – Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Insmed in a research note issued to investors on Tuesday, July 11th. Cantor Fitzgerald analyst J. Kim forecasts that the biopharmaceutical company will post earnings per share of ($4.67) for the year. The consensus estimate […]